Swift chooses PPD sleep apnea screening tool

user-gravatar Headshot

Precision Pulmonary Diagnostics (PPD), creators of an integrated sleep apnea screening and treatment program targeting the commercial vehicle industry, announced that Phoenix-based Swift Transportation Co., Inc. has chosen PPD as its comprehensive sleep apnea provider.

A 2007 project funded by the FMCSA entitled “Advanced Driver Fatigue Research” found clear indications that sleep disorders can have a significant impact on driver performance. Drivers who do not get enough sleep, have disruptive sleep patterns, or have diagnosed sleep disorders, such as sleep apnea, are at higher risk for crashes. The PPD program is aimed at identifying drivers with a high probability of sleep apnea and providing treatment, leading to improved driver health, and enhanced highway safety.

Chosen by Swift after conducting an extensive review of alternative sleep apnea detection and treatment program providers, PPD will begin by screening Swift drivers using risk factors pointing to a higher probability of sleep apnea. Using PPD’s proprietary web-based screening tool, Somni-Sage, to help identify which of its drivers may be candidates for diagnostic sleep testing and possible treatment.

“The safety and health of Swift drivers is of utmost importance to us,” said Scott Barker, director of Safety at Swift. “PPD’s program to detect and treat sleep apnea in our drivers is the industry’s most comprehensive program, one that will make the process easier for our drivers, limit downtime, and provide for the best coordination of care. We believe it will be a very positive health benefit to our drivers and will positively impact the safety of everyone on the road.”